β-lactamase-mediated β-lactam resistance in Campylobacter species: Prevalence of Cj0299 (blaOXA-61) and evidence for a novel β-lactamase in C. jejuni

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3357-3364

  Griggs, Deborah J ^a   Peake, Leanne ^a   Johnson, Margaret M ^a   Ghori, Saba ^a   Mott, A ^a   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE OXA 61; CARBENICILLIN; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; IMIPENEM; NITROCEFIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; TICARCILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER LARI; CHICKEN; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMOXICILLIN; AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BLOTTING, SOUTHERN; CAMPYLOBACTER JEJUNI; CARBENICILLIN; CEPHALOSPORINS; CHICKENS; CLOXACILLIN; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PENICILLINS; PIPERACILLIN; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TICARCILLIN;

EID: 67749142158     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01655-08     Document Type: Article

References (26)

1. Alfredson, D. A., and V. Korolik. 2005. Isolation and expression of a novel molecular class D β-lactamase, OXA-61, from Campylobacter jejuni. Antimicrob. Agents Chemother. 49:2515-2518.
2. Alfredson, D. A., and V. Korolik. 2007. Identification of putative zinc hydrolase genes of the metallo-β-lactamase superfamily from Campylobacter jejuni. FEMS Immunol. Med. Microbiol. 49:159-164.
3. Blaser, M. J. 1995. Campylobacter and related species, p. 1948-1956. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, NY.
4. Corcoran, D., T. Quinn, L. Cotter, P. Whyte, and S. Fanning. 2006. Antimicrobial resistance profiling and fla-typing of Irish thermophilic Campylobacter spp. of human and poultry origin. Lett. Appl. Microbiol. 43:560-565.
5. Fleming, P. C., A. D'Amico, S. De Grandis, and M. A. Karmali. 1982. The detection and frequency of beta-lactamase production in Campylobacter jejuni, p. 217. In D. G. Newell (ed.), Campylobacter. Epidemiology, pathogenesis and biochemistry. MTP Press, Lancaster, United Kingdom.
6. Fliegelman, R. M., R. M. Petrak, L. J. Goodman, J. Segreti, G. M. Trenholme, and R. L. Kaplan. 1985. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob. Agents Chemother. 27:429-430.
7. Gillespie, I. A., S. J. O'Brien, J. A. Frost, G. K. Adak, P. Horby, A. V. Swan, M. J. Painter, K. R. Neal, and Campylobacter Sentinel Surveillance Scheme Collaborators. 2002. A case-case comparison comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. Emerg. Infect. Dis. 9:937-942.
8. Grant, A. J., C. Coward, M. A. Jones, C. A. Woodall, P. A. Barrow, and D. J. Maskell. 2005. Signature-tagged transposon mutagenesis studies demonstrate the dynamic nature of cecal colonization of 2-week-old chickens by Campylobacter jejuni. Appl. Environ. Microbiol. 71:8031-8041.
9. Griggs, D. J., M. M. Johnson, J. A. Frost, T. Humphrey, F. Jørgensen, and L. J. V. Piddock. 2005. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob. Agents Chemother. 49:699-707.
10. Humphrey, T. J., F. Jørgensen, J. A. Frost, H. Wadda, G. Domingue, N. C. Elviss, D. J. Griggs, and L. J. V. Piddock. 2005. Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones. Antimicrob. Agents Chemother. 49:690-698.
11. Lachance, N., C. Gaudreau, F. Lamothe, and L. A. Lariviere. 1991. Role of the β-lactamase of Campylobacter jejuni in resistance to β-lactam agents. Antimicrob. Agents Chemother. 35:813-818.
12. Lachance, N., C. Gaudreau, F. Lamothe, and F. Turgeon. 1993. Susceptibilities of β-lactamase-positive and -negative strains of Campylobacter coli to β-lactam agents. Antimicrob. Agents Chemother. 37:1174-1176.
13. Lariviere, L. A., C. L. Gaudreau, and F. F. Turgeon. 1986. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. J. Antimicrob. Chemother. 18:681-685.
14. Lucain, C., H. Goossens, and J. C. Pechere. 1985. Beta-lactamases in Campylobacter jejuni, abstr. 005, p. 36-37. In A. D. Pearson, M. B. Skirrow, H. Lior, and B. Rowe (ed.), Campylobacter III. Public Health Laboratory Service, London, United Kingdom.
15. McDermott, P. F., S. M. Bodeis, F. M. Aarestrup, S. Brown, M. Traczewski, P. Fedorka-Cray, M. Wallace, I. A. Critchley, C. Thornsberry, S. Graff, R. Flamm, J. Beyer, D. Shortridge, L. J. Piddock, V. Ricci, M. M. Johnson, R. N. Jones, B. Reller, S. Mirrett, J. Aldrobi, R. Rennie, C. Brosnikoff, L. Turnbull, G. Stein, S. Schooley, R. A. Hanson, and R. D. Walker. 2004. Development of a standardized susceptibility test for campylobacter with qualitycontrol ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb. Drug Resist. 10:124-131.
16. McGill, K., D. Cowley, L. Moran, P. Scates, A. O'Leary, R. H. Madden, C. Carroll, E. McNamara, J. E. Moore, S. Fanning, J. D. Collins, and P. Whyte. 2006. Antibiotic resistance of retail food and human Campylobacter isolates on the island of Ireland from 2001-2002. Epidemiol. Infect. 134:1282-1291.
17. Mortz, E., T. N. Krogh, H. Vorum, and A. Gorg. 2001. Improved silver staining protocols for high sensitivity protein identification using matrixassisted laser desorption/ionisation-time of flight analysis. Proteomics 1:1359-1363.
18. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajandream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
19. Piddock, L. J. V., D. Griggs, M. M. Johnson, V. Ricci, N. C. Elviss, L. K. Williams, F. Jorgensen, S. A. Chisholm, A. J. Lawson, C. Swift, T. J. Humphrey, and R. J. Owen. 2008. Persistence of Campylobacter species, strain types, antibiotic resistance and mechanisms of tetracycline resistance in poultry flocks treated with chlortetracycline. J. Antimicrob. Chemother. 62: 303-315.
20. Pumbwe, L., and L. J. V. Piddock. 2002. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 206:185-189.
21. Reina, J., M. J. Ros, and A. Serra. 1994. Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob. Agents Chemother. 38:2917-2920.
22. Tajada, P., J. L. Gomez-Garces, J. I. Alos, D. Balas, and R. Cogollos. 1996. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 β-lactam agents and combinations with β-lactamase inhibitors. Antimicrob. Agents Chemother. 40:1924-1925.
23. Taylor, D. E., S. A. de Grandis, M. A. Karmali, and P. C. Fleming. 1981. Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Chemother. 19:831-835.
24. Thwaites, R. T., and J. A. Frost. 1999. Drug resistance in Campylobacter jejuni, C. coli, and C. lari isolated from humans in north west England and Wales, 1997. J. Clin. Pathol. 52:812-814.
25. United Kingdom Health Protection Agency. 2006. International surveillance network for the enteric infections Salmonella and VTEC O157: Enter-net Quarterly Campylobacter Reports. 2005-2006. United Kingdom Health Protection Agency, London, United Kingdom. http://www.hpa.org.uk/hpa/inter /enter-net-reports.htm.
26. Van Vliet, A. H. M., A. C. Wood, J. Henderson, K. Wooldridge, and J. M. Ketley. 1998. Genetic manipulation of enteric Campylobacter spp. Methods Microbiol. 27:407-419.